Estradiol derivatives bearing the side-chain of tamoxifen antagonize the association between the estrogen receptor and calmodulin
- 11 February 1994
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (4) , 748-751
- https://doi.org/10.1016/0006-2952(94)90140-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A molecular-modeling study of the interactions between the antiestrogen drug tamoxifen and several derivatives, and the calcium-binding protein calmodulinJournal of Medicinal Chemistry, 1992
- Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulinBiochemical and Biophysical Research Communications, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicityBiochemical Pharmacology, 1990
- Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.Journal of Clinical Oncology, 1989
- In VitroInteraction of Estradiol Receptor with Ca2+-CalmodulinMolecular Endocrinology, 1988
- Influence of new hydroxylated Triphenylethylene (TPE) derivatives on estradiol binding to uterine cytosolJournal of Steroid Biochemistry, 1984
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterusMolecular and Cellular Endocrinology, 1982
- Molecular details of receptor binding and hormonal action of steroids derived from X-ray crystallographic investigationsJournal of Steroid Biochemistry, 1981